These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 21741942)

  • 1. Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation.
    Bekes EM; Schweighofer B; Kupriyanova TA; Zajac E; Ardi VC; Quigley JP; Deryugina EI
    Am J Pathol; 2011 Sep; 179(3):1455-70. PubMed ID: 21741942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis.
    Ardi VC; Kupriyanova TA; Deryugina EI; Quigley JP
    Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20262-7. PubMed ID: 18077379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.
    Deryugina EI; Zajac E; Juncker-Jensen A; Kupriyanova TA; Welter L; Quigley JP
    Neoplasia; 2014 Oct; 16(10):771-88. PubMed ID: 25379015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway.
    Ardi VC; Van den Steen PE; Opdenakker G; Schweighofer B; Deryugina EI; Quigley JP
    J Biol Chem; 2009 Sep; 284(38):25854-66. PubMed ID: 19608737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of matrix metalloproteinases and tissue inhibitors of metalloproteinases differentially expressed by variants of human HT-1080 fibrosarcoma exhibiting high and low levels of intravasation and metastasis.
    Partridge JJ; Madsen MA; Ardi VC; Papagiannakopoulos T; Kupriyanova TA; Quigley JP; Deryugina EI
    J Biol Chem; 2007 Dec; 282(49):35964-77. PubMed ID: 17895241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9.
    Zajac E; Schweighofer B; Kupriyanova TA; Juncker-Jensen A; Minder P; Quigley JP; Deryugina EI
    Blood; 2013 Dec; 122(25):4054-67. PubMed ID: 24174628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1.
    Ries C; Pitsch T; Mentele R; Zahler S; Egea V; Nagase H; Jochum M
    Biochem J; 2007 Aug; 405(3):547-58. PubMed ID: 17489740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
    Ogata Y; Itoh Y; Nagase H
    J Biol Chem; 1995 Aug; 270(31):18506-11. PubMed ID: 7629179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination.
    Deryugina EI; Zijlstra A; Partridge JJ; Kupriyanova TA; Madsen MA; Papagiannakopoulos T; Quigley JP
    Cancer Res; 2005 Dec; 65(23):10959-69. PubMed ID: 16322244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis.
    Shamamian P; Schwartz JD; Pocock BJ; Monea S; Whiting D; Marcus SG; Mignatti P
    J Cell Physiol; 2001 Nov; 189(2):197-206. PubMed ID: 11598905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion.
    Stearns ME; Rhim J; Wang M
    Clin Cancer Res; 1999 Jan; 5(1):189-96. PubMed ID: 9918218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
    Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
    Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
    Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
    Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
    J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasion.
    Conn EM; Botkjaer KA; Kupriyanova TA; Andreasen PA; Deryugina EI; Quigley JP
    Am J Pathol; 2009 Oct; 175(4):1638-52. PubMed ID: 19729488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases.
    Hahn-Dantona E; Ramos-DeSimone N; Sipley J; Nagase H; French DL; Quigley JP
    Ann N Y Acad Sci; 1999 Jun; 878():372-87. PubMed ID: 10415742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice.
    Stearns ME; Garcia FU; Fudge K; Rhim J; Wang M
    Clin Cancer Res; 1999 Mar; 5(3):711-20. PubMed ID: 10100726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses.
    Fujimoto N; Ward RV; Shinya T; Iwata K; Yamashita K; Hayakawa T
    Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):827-33. PubMed ID: 8611162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide from the C-terminal domain of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) inhibits membrane activation of matrix metalloproteinase-2 (MMP-2).
    Xu X; Mikhailova M; Chen Z; Pal S; Robichaud TK; Lafer EM; Baber S; Steffensen B
    Matrix Biol; 2011 Sep; 30(7-8):404-12. PubMed ID: 21839835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.